Source - SMW
Syncona noted that its portfolio company Autolus Therapeutics had filed to undertake a proposed public offering in the US of its American depositary shares.

The proposed maximum aggregate offering amount specified in the filing was 4m ADSs.

Their final price would be determined following a bookbuilding process.